`
`Exhibit 17
`
`
`
`Case 1:20-cv-00393-LMB-WEF Document 1462-17 Filed 04/05/23 Page 2 of 4 PageID# 39715
`Case: 22-1227 Document: 39 Page: 1 Filed: 03/21/2022
`
`
`No. 22-1227
`
`
`
`United States Court of Appeals
`for the Federal Circuit
`
`PHILIP MORRIS PRODUCTS S.A., PHILIP MORRIS USA, INC.,
`ALTRIA CLIENT SERVICES LLC,
`Appellants,
`
`
`
`
`
`
`
`
`
`v.
`INTERNATIONAL TRADE COMMISSION,
`Appellee,
`
`
`
`
`
`RAI STRATEGIC HOLDINGS, INC., R.J. REYNOLDS VAPOR COMPANY,
`R.J. REYNOLDS TOBACCO COMPANY,
`Intervenors.
`
`
`
`
`
`______________________________________________
`On Appeal from the United States International Trade Commission
`in Investigation No. 337-TA-1199
`______________________________________________
`NONCONFIDENTIAL BRIEF OF APPELLANTS
`______________________________________________
`Gregory G. Garre
`Maximilian A. Grant
`Bert C. Reiser
`Jamie D. Underwood
`Gabriel K. Bell
`LATHAM & WATKINS LLP
`555 Eleventh Street, NW, Suite 1000
`Washington, DC 20004
`(202) 637-2200
`Counsel for Appellants
`
`
`
`
`
`
`
`
`
`
`
`
`March 21, 2022
`
`
`
`
`
`
`
`Case 1:20-cv-00393-LMB-WEF Document 1462-17 Filed 04/05/23 Page 3 of 4 PageID# 39716
`Case: 22-1227 Document: 39 Page: 83 Filed: 03/21/2022
`
`
`And IQOS’s MRTP authorization allows Appellants to communicate with U.S.
`
`consumers about the reduced exposure benefits IQOS provides. No other inhalable
`
`smoke-free CC alternatives can do so lawfully, and none will be able to do so for
`
`years, as there are no MRTP applications even pending for such alternatives.
`
`Appx41387; Appx41104; Appx21343, Appx21358 (Tr. 1409:12-23, 1468:8-15);
`
`Appx20874, Appx20876 (Tr. 101:5-7, 109:4-9); FDA, Modified Risk Granted
`
`Orders,
`
`Decision
`
`Summary
`
`MR0000133
`
`(July
`
`7,
`
`2020),
`
`https://www.fda.gov/tobacco-products/advertising-and-promotion/modified-risk-
`
`orders.
`
`
`
`Second, no other CC alternative provides the same ritual, sensory experience,
`
`or satisfaction as IQOS. As organizations, physicians, and IQOS users told the
`
`Commission, IQOS is not interchangeable with other products; it plays a unique and
`
`vital role in reducing CC smoking. Supra at 11-12; Appx21295, Appx21299 (Tr.
`
`1347:1-24; 1349:13-17, 1350:1-5, 1366:4-9); Appx21360 (Tr. 1479:17-23);
`
`Appx20865 (Tr. 67:16-24); Appx21140 (Tr. 840:9-25); Appx21273-21274 (Tr.
`
`1260:14-18, 1263:9-25).18
`
`
`18 See Appx41200-41201; Appx41256; Appx41432-41433; Appx40941;
`Appx40965-40966; Appx41981; Appx14003-14004; Appx13942; Appx13916;
`Appx13998; Appx13927; Appx13987; Appx13977; Appx14007; Appx14011;
`Appx13988; Appx13990; Appx14005; Appx13995; Appx13989; Appx13914-
`13918.
`
`69
`
`
`
`Case 1:20-cv-00393-LMB-WEF Document 1462-17 Filed 04/05/23 Page 4 of 4 PageID# 39717
`Case: 22-1227 Document: 39 Page: 85 Filed: 03/21/2022
`
`
`
`
`Nicotine replacement therapies are designed to stop all nicotine intake.
`
`Appx41594-41595 (Gilchrist Dep. 32:16-33:20); Appx21140 (Tr. 839:4-16);
`
`Appx21295 (Tr. 1349:6-10). Those are, therefore, fundamentally different from
`
`IQOS and regulated in a different manner. Appx21295 (Tr. 1349:10-12);
`
`Appx40959; 21 U.S.C. §§ 321(rr), 387k.
`
`In sum, the lack of lawful, effective alternatives should have weighed heavily
`
`in the Commission’s public interest analysis. But it did not.
`
`CONCLUSION
`
`The Commission’s determination and orders should be reversed or vacated.
`
`Dated: March 21, 2022
`
`Respectfully submitted,
`
`
`
`
`
`
`/s/ Gregory G. Garre
`Gregory G. Garre
`Maximilian A. Grant
`Bert C. Reiser
`Jamie D. Underwood
`Gabriel K. Bell
`LATHAM & WATKINS LLP
`555 Eleventh Street, NW, Suite 1000
`Washington, DC 20004
`(202) 637-2200
`gregory.garre@lw.com
`
`Counsel for Appellants Philip Morris
`Products S.A., Philip Morris USA,
`Inc., and Altria Client Services LLC
`
`71
`
`
Accessing this document will incur an additional charge of $.
After purchase, you can access this document again without charge.
Accept $ Charge
Still Working On It
This document is taking longer than usual to download. This can happen if we need to contact the court directly to obtain the document and their servers are running slowly.
Give it another minute or two to complete, and then try the refresh button.
A few More Minutes ... Still Working
It can take up to 5 minutes for us to download a document if the court servers are running slowly.
Thank you for your continued patience.
This document could not be displayed.
We could not find this document within its docket. Please go back to the docket page and check the link. If that does not work, go back to the docket and refresh it to pull the newest information.
Your account does not support viewing this document.
You need a Paid Account to view this document. Click here to change your account type.
Your account does not support viewing this document.
Set your membership
status to view this document.
With a Docket Alarm membership, you'll
get a whole lot more, including:
- Up-to-date information for this case.
- Email alerts whenever there is an update.
- Full text search for other cases.
- Get email alerts whenever a new case matches your search.
One Moment Please
The filing “” is large (MB) and is being downloaded.
Please refresh this page in a few minutes to see if the filing has been downloaded. The filing will also be emailed to you when the download completes.
Your document is on its way!
If you do not receive the document in five minutes, contact support at support@docketalarm.com.
Sealed Document
We are unable to display this document, it may be under a court ordered seal.
If you have proper credentials to access the file, you may proceed directly to the court's system using your government issued username and password.
Access Government Site
